In collaboration with the Barcelona Science Park (PCB), IRB Barcelona will be participating in Science Week, the largest public communications event on science and technology in Spain, which this year reached its 15th series. Coordinated by the “Fundació Catalana per a la Recerca i la Innovació” (FCRI), the programme of activities will be held from 12 to 22 November.
The activities include open days on 16 and 18 November. Entitled “Come and do an express PhD”, through a series of clues visitors will analyse the differences between malignant and benign tumour cells. In this regard, they will visit Eduard Batlle’s lab, the Advanced Digital Microscopy Platform and the “Centro...
The new data base, which includes 1,700 proteins in motion, allows a more efficient design of drugs.
MoDEL holds 30% of human therapeutic targets and the objective is to cover 80% in three years.
The biotech enterprise Omnia Molecular, which operates from the PCB-Santander Bioincubator at the Barcelona Science Park and was founded by IRB Barcelona researcher Lluís Ribas de Pouplana, has closed funding negotiations headed by “Caixa Capital Risc”, the risk capital section of “la Caixa", worth 2.1M€ . This round of funding, which is supported by the Empresa Nacional de Innovación (ENISA), has also involved the founding partners of Omnia Molecular (Lluís Ribas, Juan Gargallo y Eugeni Roure) and the new managerial team, comprised by Raphael Klingmann, who serves as CEO, and Dariusch Mani.
Omnia Molecular is devoted to the discovery and...
Researchers Dario Alessi and Joan Guinovart bring together 150 experts in cancer Metabolism in a Barcelona BioMed Conference, organised by IRB Barcelona and the BBVA Foundation.
Today, Joan J. Guinovart, director of the Institute for Research in Biomedicine (IRB Barcelona), has been admitted as a new member to the “Reial Acadèmia de Farmàcia de Catalunya” (Catalan Royal Academy of Pharmacy).
This finding has brought them the “Paper of the week” of the Journal of Biological Chemistry, one of the journals of greatest impact in basic biology.
Called SLIMP, the protein is required for mitochondria maintenance, the cellular powerhouses.
15% of the deaths from cancer are associated with chronic infections accompanied by inflammation.
IRB Barcelona sets up a system in mice to study the behaviour of key cells in the inflammatory process, namely macrophages, in cancer models.
The next Barcelona BioMed Conference brings together leading international experts in inflammation and disease.
Xavier Salvatella has been awarded a project by the Fundació La Marató de TV3 funded with 397,000 € to study Kennedy’s disease, a neurodegenerative condition.
The project is coordinated with the Institute of Biomedicine of the University of Barcelona (IBUB) and the University of Cambridge.
This refers to Intrinsically Disordered Proteins, which were discovered ten years ago thanks to the sequencing of the genome.
Many of these proteins are involved in key cellular processes and in pathologies of great impact such as cancer and neurodegeneration.
In the next Barcelona Biomed Conference, IRB Barcelona and the BBVA Foundation bring together 150 world authorities in this field, which is called upon to revolutionalize biomedicine.
In the journal Science Signaling, Andreu Casali describes a sophisticated mechanism related to the protein Hedgehog.